for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

RCOM Homepage IN

Interview: George Yancopoulos, Regeneron

Posted

Regeneron’s Chief Scientific Officer, George Yancopoulos brings Reuters Editor at Large Axel Threlfall up to speed on where the biotech is with its two potential covid-19 therapies and tells him the first clinical trial results of one of those treatments, Kevzara, could be just weeks away.

RCOM Homepage IN

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up